Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023

Rhea-AI Summary

Silk Road Medical, Inc. (Nasdaq: SILK) will release its first quarter 2023 financial results on May 9, 2023, after market close, followed by an audio webcast at 1:30 p.m. PT. The company, based in Sunnyvale, California, specializes in reducing stroke risk through its innovative TransCarotid Artery Revascularization (TCAR) procedure. This method merges surgical neuroprotection with minimally invasive techniques to address carotid artery blockages.

Interested parties can register for the conference call online and join the live or replay webcast to gain insights into the company’s financial performance and future outlook.

Positive

• Scheduled financial results release for Q1 2023 on May 9, 2023.
• Management will provide insights via a live audio webcast.

Negative

• None.

SUNNYVALE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9^th, 2023. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should register online using this link. Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the webcast will be available at https://investors.silkroadmed.com.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com

FAQ

What date will Silk Road Medical report its Q1 2023 financial results?

Silk Road Medical will report its Q1 2023 financial results on May 9, 2023.

What is the TransCarotid Artery Revascularization (TCAR) procedure?

TCAR is a minimally invasive treatment for carotid artery disease that combines surgical neuroprotection with endovascular techniques.

When is the audio webcast for Silk Road Medical's financial results?

The audio webcast will take place on May 9, 2023, at 1:30 p.m. Pacific Time.

How can I register for the Silk Road Medical conference call?

You can register for the conference call online via the provided link in the press release.